CEA(6D)VRP, NCT00529984: A Phase I/II Study With CEA(6D) VRP Vaccine in Patients With Advanced or Metastatic CEA-Expressing Malignancies |
|
|
| Completed | 1/2 | 28 | US | AVX701 | AlphaVax, Inc., Duke University | Colorectal Cancer, Breast Cancer, Lung Cancer, Pancreatic Cancer, Colon Cancer | 05/10 | 05/10 | | |
